Recent Patents on CNS Drug Discovery (Discontinued)


Vincenzo Di Marzo
Istituto di Chimica Biomolecolare (I.C.B.)
Consiglio Nazionale delle Ricerche (C.N.R.)
Via Campi Flegrei 34
Pozzuoli, Napoli 80078

Personal Subscription

Advances in the Discovery of Novel Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor

Volume:2   Issue: 2
Pp: 99-106
Ramin Faghih, Gregory A. Gfesser and Murali Gopalakrishnan
DOI: 10.2174/157488907780832751

GPCR Drug Discovery: Novel Ligands for CNS Receptors

Volume:2   Issue: 2
Pp: 107-112
William K. Lim
DOI: 10.2174/157488907780832689

The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders

Volume:2   Issue: 2
Pp: 125-129
Rafael Roesler, Flavio Kapczinski, Joao Quevedo, Felipe Dal Pizzol and Gilberto Schwartsmann
DOI: 10.2174/157488907780832742

The Seek of Neuroprotection: Introducing Cannabinoids

Volume:2   Issue: 2
Pp: 131-139
Jose Martinez-Orgado, David Fernandez-Lopez, IgnacioLizasoain and Julian Romero
DOI: 10.2174/157488907780832724

Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of Dementia

Volume:2   Issue: 2
Pp: 145-149
Masahiro Kawahara, Keiko Konoha, Tetsuya Nagata and Yutaka Sadakane
DOI: 10.2174/157488907780832698

Dexmedetomidine: A Novel Anesthetic Agent for Middle Ear Surgery

Volume:2   Issue: 2
Pp: 151-154
Yezdan Firat and Erol Selimoglu
DOI: 10.2174/157488907780832760

Patent Selections promotion: free to download

Volume:2   Issue: 2
Pp: 167-172
Bentham Science Publishers
DOI: 10.2174/157488907780832706